Status
Conditions
Treatments
About
This project investigates the effects of the Blood-Flow-Restriction (BFR) training method on postoperative muscle atrophy and pain after spinal surgery. Two groups are formed for this purpose. The intervention group receives a everyday BFR training during the postoperative stay at an individually measured occlusion pressure of 60-80%. The control group performs sham-BFR training at a fixed occlusion pressure of 20mmHg. The examinations are carried out before and several times after the operation (longest follow-up: 6 months). Among other things, muscle mass, muscle strength, pain perception and quality of life are assessed using questionnaires.
Full description
Methodology and implementation Type of study
Prospective, interventional study in the context of clinical orthopedic routine (Non-AMG, Non-MPG):
This scientific project investigates the influence of blood-flow restriction training as a therapeutic intervention after spinal surgery for postoperative muscle preservation.
Study design Parallel study design The aim of this study is to investigate the influence of postoperative blood-flow restriction (BFR) application on muscle preservation and muscular-functional rehabilitation after spinal surgery. Postoperative muscle mass and strength loss is related not only to the size of the surgical procedure, but also to the prolonged rehabilitation after spine surgery. Since our patients are not able to perform large mechanical loads for a longer period of time (usually six weeks), we use the BFR training method as a training intervention.
The thesis of this work focuses the postoperative use of BFR training to reduce muscle atrophy during hospitalisation phase, and the supporting effects of BFR-Training on functional rehabilitation. For this purpose, a partially blinded randomised controlled trial will treat one group with BFR and one group with Sham-BFR and compare the results.
Classification of patients and study procedure Subjects who fulfil the above-mentioned inclusion criteria for study participation will be informed orally and by means of an information sheet about the planned study by the investigator and given written information.
Prior to the start of the study, the written consent of the subjects to participate in the study will be obtained. The study takes into account the ethical principles of the Declaration of Helsinki in its current version (2013).
Randomisation of patients The patients will be divided into two groups of 25 patients each. Randomisation will be done by classical analogue double lottery.
Description of the interventions Intervention: Blood-Flow Restriction Training (BFR). BFR training involves the application of tourniquets during a passive or active movement intervention to provide an additive metabolic stimulus. The tourniquets are applied as far as possible proximally to the thigh and a pressure is applied during the movement that suppresses only part of the venous return of an extremity (=venous pooling). Venous occlusion is induced by a cuff system routinely used in strength training (Delfi Medical Innovations Inc., Vancouver, Canada). The pressure applied is calculated on the basis of the individual occlusion pressure via duplex sonography at the start of each training session. The test person lies at rest while the cuff is inflated until no more blood flow can be detected in the extremity (= occlusion pressure). Of this occlusion pressure, 60-80% is subsequently used for the BFR intervention. The loading protocol provides for daily units of 60 minutes at intervals (5 minutes occlusion + 5 minutes free flow, six times in total), over a period of two to 14 days.
Control: Control group, Sham-BFR (CG). Patients in the control group (CG) perform the same exercise protocol as patients in the BFR intervention group, except that they receive the standardized low BFR pressure of 20mmHg.
Investigation/aim parameters of the study Investigations For the purpose of this project, the examinations will be divided into basal examinations and in-rehabilitation examinations.
Study population
Patient inclusion criteria:
Patient exclusion criteria:
Number of patients: 50 (two groups with 25 subjects each)
Discontinuation of the study in one patient (drop-out)
One or more of the following circumstances may lead to a patient dropping out of the study (this patient will be counted as a drop-out):
Statistical calculation of the number of cases A power analysis performed using G*Power 3.1.9. assuming a mean effect size (f) of 0.25, an alpha error of 0.05 and a test power of (1-β) of 0.85 for the analysis of variance with repeated measures resulted in an optimal sample size of N = 26 (i.e. 13 subjects per group).
Because of the long follow-up period of 6 months and the resulting increased possibility of drop-out patients, we agreed on a number of 25 subjects per group.
Recruitment measures The patients will be recruited from the patient pool of the Department of Orthopaedics and Trauma Surgery of the University Hospital Bonn.
Archiving and data protection All data generated in the course of the study are protected by data protection laws. Personal data will not be passed on or made accessible to the public by the medically responsible study director or the investigator (Alexander Franz) or any other person involved in the conduct of the study. Only pseudonymized patient data will be passed on and stored. The pseudonymization is carried out by means of an ascending numerical series by the medically responsible study director or the investigator. Only the investigators are allowed to assign the personal data to the study data. The allocation key is stored on an external hard drive and is managed by the principal investigator (Alexander Franz). After completion of the study, the allocation key is deleted and the data management is changed from pseudonymization to anonymization. The evaluation of the data will be anonymized. All data will be managed in accordance with data protection regulations.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
50 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal